Back to User profile » Prof. Dr. Juei-Tang Cheng
Papers published by Prof. Dr. Juei-Tang Cheng:
Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats
Kuo FY, Cheng KC, Li Y, Cheng JT, Tsai CC
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2269-2277
Published Date: 29 June 2020
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT
Diabetes, Metabolic Syndrome and Obesity 2018, 11:901-911
Published Date: 7 December 2018
Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals
Li Y, Cheng KC, Niu C, Lo S, Cheng JT, Niu H
Drug Design, Development and Therapy 2017, 11:1127-1134
Published Date: 5 April 2017
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
Lo SH, Cheng KC, Li YX, Chang CH, Cheng JT, Lee KS
Drug Design, Development and Therapy 2016, 10:2669-2676
Published Date: 22 August 2016
Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
Niu HS, Chang CH, Niu CS, Cheng JT, Lee KS
Drug Design, Development and Therapy 2016, 10:1877-1884
Published Date: 3 June 2016
Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats
Niu HS, Liu IM, Niu CS, Ku PM, Hsu CT, Cheng JT
Drug Design, Development and Therapy 2016, 10:971-978
Published Date: 2 March 2016
Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
Niu HS, Ku PM, Niu CS, Cheng JT, Lee KS
Drug Design, Development and Therapy 2015, 9:5625-5632
Published Date: 14 October 2015
Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats
Lin CM, Tsai JT, Chang CK, Cheng JT, Lin JW
Drug Design, Development and Therapy 2015, 9:4709-4717
Published Date: 14 August 2015